WebDoctor Encyclopedia

Head & neck

Polymorphous adenocarcinoma (salivary gland)

Polymorphous adenocarcinoma is an uncommon salivary gland cancer that usually starts in the palate. It grows slowly, mostly affects people in their 50s to 70s, and is generally cured by surgery, although local recurrence can occur years later.

Medically reviewed Last reviewed October 19, 2026

What is polymorphous adenocarcinoma?

Polymorphous adenocarcinoma (PAC) is a low-grade cancer of the salivary glands. It almost always starts in the minor salivary glands, the hundreds of tiny glands that line the inside of the mouth, and most often in the roof of the mouth (the palate).

The word “polymorphous” means “many shapes”. Under the microscope, the tumour cells look fairly uniform, but they are arranged in many different patterns: solid nests, tubes, cords, strands and sieve-like areas. Until 2017 the tumour was called polymorphous low-grade adenocarcinoma (PLGA).

PAC is the second most common cancer of the minor salivary glands after mucoepidermoid carcinoma. It usually affects adults between 50 and 70 and is about twice as common in women as in men.

Most PACs grow slowly and are cured by surgery. However, the tumour likes to grow along nerves, and it can come back many years later, so long-term follow-up is important (Katabi and Xu, 2021). A related form, the cribriform subtype, more often spreads to lymph nodes in the neck.

1. Key facts at a glance

Feature Details
Type of cancer Low-grade salivary gland adenocarcinoma
How common Uncommon; second most frequent minor salivary gland cancer
Typical age Adults, mostly 50-70; average late 50s
Sex About twice as common in women
Main site Palate (about 6 in 10); also lip, cheek, tongue, gums, base of tongue
Key gene changes PRKD1 hotspot mutation (classic type); PRKD1, PRKD2 or PRKD3 fusions (cribriform subtype)
Main treatment Wide surgical removal; radiotherapy in selected cases
Outlook Excellent; disease-related death is rare
Special feature Late local recurrence, sometimes after 10 years or more

2. Types of polymorphous adenocarcinoma

Type Usual site Main gene change Behaviour
Classic PAC Palate and other minor glands of the mouth PRKD1 point mutation (E710D) in most Low risk of spread; occasional late local recurrence
Cribriform subtype Base of tongue, back of the mouth and throat Fusions of PRKD1, PRKD2 or PRKD3 More often spreads to neck lymph nodes, sometimes at diagnosis

The cribriform subtype was first described as cribriform adenocarcinoma of salivary glands (CASG). Experts still debate whether it is a variant of PAC or a separate tumour (Weinreb et al., 2014; Sebastiao et al., 2020).

3. Causes and risk factors

The cause of PAC is not known. It does not appear to be linked to smoking, alcohol or the human papillomavirus (HPV), which are important causes of other mouth and throat cancers.

Factor Notes
Age Mostly middle-aged and older adults
Female sex Women are affected more often
Previous radiation A general risk factor for salivary cancers, but rarely relevant here

Gene changes

Gene change Notes
PRKD1 E710D mutation A single-letter change in the PRKD1 gene, found in about three-quarters of classic tumours
PRKD1, PRKD2 or PRKD3 rearrangements Typical of the cribriform subtype
Other changes Occasional alterations in other growth-signalling genes (Fukumura et al., 2022)

These changes arise only in the tumour cells. They are not inherited and cannot be passed on to children.

4. How does it look

In the mouth

Feature Description
Shape A firm, smooth, rounded swelling
Colour Usually the same as the surrounding lining, sometimes bluish or reddish
Surface Usually intact; ulceration is unusual
Size Often 1-3 cm
Position Commonly at the junction of the hard and soft palate
Feel Firm and fixed to the underlying tissue

On scans

CT shows whether the tumour has worn away the bone of the palate. MRI is better for showing the soft tissues and for spotting spread along nerves, which can extend towards the skull base. Ultrasound or CT of the neck checks the lymph nodes.

Under the microscope

Feature Description
Cells Uniform, bland cells with pale oval nuclei
Patterns Solid, tubular, trabecular, cribriform, papillary and single-file strands, often in the same tumour
Targetoid pattern Rings of cells around nerves or small vessels
Edges Infiltrative, despite a well-defined look to the naked eye
Nerve invasion Common
Stains S100 and SOX10 positive; CK7 positive; p63 often positive while p40 is usually negative

Conditions that can look similar

PAC is most often confused with adenoid cystic carcinoma, which is more aggressive, and with pleomorphic adenoma, a common benign tumour. Small biopsies can make these distinctions difficult, so review by a specialist head and neck pathologist is valuable (Katabi and Xu, 2021).

Why does PAC grow along nerves?

Many salivary gland cancers, including PAC and adenoid cystic carcinoma, show perineural invasion, which means the tumour cells spread in the thin sheath around nerves. This allows the tumour to travel beyond the visible lump, sometimes towards the base of the skull. It explains why surgeons aim for a wide margin, why MRI is used to check the nerves, and why some people are offered radiotherapy when the surgical margins are close.

5. Symptoms

PAC usually causes few symptoms at first, and many people notice the lump by chance.

Common symptoms

  • A painless lump or swelling on the roof of the mouth
  • A swelling of the lip, cheek or gum
  • A lump that has been present for months or years, growing slowly
  • Poorly fitting dentures because of the swelling
  • Bleeding if the surface is injured

Less common symptoms

Symptom What it may mean
Pain or tenderness Growth along nerves
Numbness of the palate, teeth or face Nerve involvement
Loose teeth Bone involvement near the gums
Lump in the neck Lymph node spread, more typical of the cribriform subtype
Difficulty swallowing or a feeling of something in the throat Tumour at the base of the tongue

When to seek medical advice

See a dentist or doctor about any lump, ulcer or swelling in the mouth that lasts more than 3 weeks. Many mouth lumps are harmless, but a persistent firm swelling on the palate should be checked and usually biopsied.

6. Diagnosis

Test Purpose
Examination of the mouth and neck Assesses the lump, nearby teeth and lymph nodes
Incisional biopsy Removes a small piece of tissue under local anaesthetic
Immunohistochemistry Helps separate PAC from adenoid cystic carcinoma and other tumours
Molecular testing Detects PRKD1 mutation or PRKD fusions in difficult cases
CT scan Checks for bone involvement
MRI scan Shows soft-tissue extent and nerve spread
Neck ultrasound or CT Looks for lymph node spread

Staging

Like other cancers of the mouth and salivary glands, PAC is staged with the TNM system:

Part What it describes
T (tumour) Size and depth, and whether it invades bone, nerves or neighbouring areas
N (nodes) Whether lymph nodes in the neck contain cancer
M (metastasis) Whether cancer has spread to distant organs, which is rare

7. Treatment

Treatment is planned by a head and neck cancer team, including oral and maxillofacial surgeons, ENT surgeons, oncologists and restorative dentists.

Surgery

Approach Notes
Wide local excision Removes the tumour with a margin of healthy tissue; the main treatment
Partial maxillectomy Removes part of the palate and upper jaw bone when the tumour is close to or into bone
Reconstruction An obturator (a dental plate that fills the gap) or a tissue flap
Neck dissection When neck nodes are enlarged, and considered for the cribriform subtype

Complete removal with clear margins is the most important step for lowering the risk of recurrence (Paleri, Robinson and Bradley, 2008).

Radiotherapy

Radiotherapy after surgery is not needed for most people. It may be advised for:

  • Positive or close margins that cannot be widened
  • Extensive nerve invasion
  • Large or recurrent tumours
  • Lymph node spread

Treatment of recurrent or advanced disease

Option Notes
Further surgery Often successful for local recurrence
Radiotherapy For local control when surgery is not possible
Systemic treatment Rarely needed; based on tumour profiling or clinical trials

Obturators explained

When part of the palate is removed, a gap can be left between the mouth and the nose or sinus. An obturator is a custom-made dental plate that closes this gap.

Stage What happens
Before surgery A dentist takes impressions of the mouth to make a temporary plate
At surgery A surgical obturator is fitted to protect the wound and allow speech and swallowing
First weeks The plate is adjusted as swelling settles and the area heals
Months later A permanent, more comfortable obturator is made, sometimes carrying replacement teeth
Alternatives Some people have the gap closed with their own tissue (a flap) instead

Most people learn to speak, eat and drink normally with a well-fitting obturator.

Side effects

Treatment Possible side effects
Palate surgery Speech and swallowing changes until healed or an obturator is fitted; nasal-sounding speech
Neck dissection Shoulder stiffness, numbness, swelling
Radiotherapy Dry mouth, sore mouth, taste changes, dental decay, jaw stiffness

What treatment involves day to day

Part of treatment What to expect
Small excision Often a day case or one night in hospital
Partial maxillectomy A few days in hospital; an obturator is fitted during or after surgery
Healing Soft diet for 1-3 weeks
Radiotherapy, if needed Weekday sessions for about 6 weeks

8. Outlook (prognosis)

Measure Usual result
Disease-specific survival Very high; deaths from PAC are rare
Local recurrence Seen in a minority, often after many years
Neck node spread Uncommon in classic PAC; more frequent in the cribriform subtype
Distant spread Rare

Because the tumour grows so slowly, a recurrence may only become noticeable 10 or even 20 years after the first operation. Recurrences can often be treated successfully with further surgery. Factors linked with recurrence include positive margins, large size, bone involvement and, in some series, nerve invasion (Katabi and Xu, 2021).

9. Follow-up

Follow-up Purpose
Mouth and neck examination every 3-6 months at first Detects recurrence early
MRI or CT If symptoms change or the area is hard to examine
Dental and obturator review Maintains fit, comfort and oral health
Long-term follow-up, often 10 years or more Because late recurrence is typical

10. Living with polymorphous adenocarcinoma

  • Keep up dental care, with regular check-ups and good oral hygiene
  • Clean your obturator daily and have it adjusted as the area heals
  • Ask for speech and swallowing therapy if needed
  • Report any new lump, ulcer, pain or numbness in the mouth
  • Avoid smoking and limit alcohol, which harm healing and oral health
  • Seek support from head and neck cancer charities and patient groups

11. Frequently asked questions

Question Answer
Is polymorphous adenocarcinoma serious? It is a cancer, but usually low grade with an excellent outlook
Is it caused by smoking? No clear link has been found
Is it inherited? No
Will I need chemotherapy? Almost never
Why do I need follow-up for so long? The tumour can come back many years after surgery
Can I wear dentures afterwards? Usually yes; an obturator can carry replacement teeth
What is the cribriform subtype? A related form, often at the base of the tongue, that spreads to neck nodes more often

12. Questions to ask your care team

  • Is my tumour classic PAC or the cribriform subtype?
  • Were the margins clear?
  • Is there nerve or bone involvement?
  • Do I need radiotherapy or a neck dissection?
  • Will I need an obturator or reconstruction?
  • How long will follow-up last?

Resources

  1. Fukumura, M. et al. (2022) ‘Salivary gland polymorphous adenocarcinoma: clinicopathological features and gene alterations in 36 Japanese patients’, Journal of Oral Pathology and Medicine, 51(8), pp. 710-720.
  2. Katabi, N. and Xu, B. (2021) ‘Polymorphous adenocarcinoma’, Surgical Pathology Clinics, 14(1), pp. 127-136.
  3. Paleri, V., Robinson, M. and Bradley, P. (2008) ‘Polymorphous low-grade adenocarcinoma of the head and neck’, Current Opinion in Otolaryngology and Head and Neck Surgery, 16(2), pp. 163-169.
  4. Sebastiao, A.P.M. et al. (2020) ‘Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes’, Modern Pathology, 33(1), pp. 65-73.
  5. Weinreb, I. et al. (2014) ‘Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin’, Genes, Chromosomes and Cancer, 53(10), pp. 845-856.
  6. National Cancer Institute (2026) Salivary Gland Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/head-and-neck/hp/adult/salivary-gland-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.